PLEASE NOTE: Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP).
Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org.
Wed, 05/26/2021 - 15:31
#1
Melissa Bishop
Offline
Last seen: 5 months 2 weeks ago
Joined: 08/12/2014 - 15:29
DOAC P&P for peds
I would be interested in what your policy is if you are using DOACs for pediatric patients. Thanks in advance. Rivaroxaban is our current formulary item. We may add it to our High Alert Medication list soon...